Here's Why We Think Immatics N.V.'s (NASDAQ:IMTX) CEO Compensation Looks Fair for the Time Being
Here's Why We Think Immatics N.V.'s (NASDAQ:IMTX) CEO Compensation Looks Fair for the Time Being
Key Insights
主要見解
- Immatics' Annual General Meeting to take place on 20th of June
- CEO Harpreet Singh's total compensation includes salary of €488.0k
- Total compensation is similar to the industry average
- Immatics' total shareholder return over the past three years was 7.5% while its EPS grew by 49% over the past three years
- Immatics的年度股東大會將於6月20日舉行。
- 首席執行官Harpreet Singh的總薪酬包括488.0萬歐元的工資。
- 總補償與行業平均水平相似
- 過去三年，Immatics的總股東回報率爲7.5%，而EPS在過去三年增長了49%。
Under the guidance of CEO Harpreet Singh, Immatics N.V. (NASDAQ:IMTX) has performed reasonably well recently. This is something shareholders will keep in mind as they cast their votes on company resolutions such as executive remuneration in the upcoming AGM on 20th of June. We present our case of why we think CEO compensation looks fair.
在首席執行官Harpreet Singh的指導下，Immatics N.V.（納斯達克代碼：IMTX）近期表現合理。這是股東們在如執行薪酬等公司決議的表決時會記在心中的事情。我們列出我們爲什麼認爲首席執行官薪酬看起來公平的理由。
Comparing Immatics N.V.'s CEO Compensation With The Industry
將Immatics N.V.的首席執行官薪酬與行業行情進行比較。
At the time of writing, our data shows that Immatics N.V. has a market capitalization of US$1.3b, and reported total annual CEO compensation of €6.4m for the year to December 2023. We note that's a decrease of 15% compared to last year. We think total compensation is more important but our data shows that the CEO salary is lower, at €488k.
截至撰寫本文時，我們的數據顯示Immatics N.V.的市值爲13億美元，其報告的截至2023年12月的總年度首席執行官薪酬爲640萬歐元。我們注意到這相對於去年減少了15%。我們認爲總薪酬更爲重要，但我們的數據顯示首席執行官的工資較低，爲488,000歐元。
In comparison with other companies in the American Biotechs industry with market capitalizations ranging from US$1.0b to US$3.2b, the reported median CEO total compensation was €6.6m. From this we gather that Harpreet Singh is paid around the median for CEOs in the industry. Furthermore, Harpreet Singh directly owns US$17m worth of shares in the company, implying that they are deeply invested in the company's success.
與行業市值在10億美元至32億美元範圍內的其他美國生物科技公司相比，報告的首席執行官總薪酬中位數爲660萬歐元。從這我們得出Harpreet Singh的薪酬大約是行業內首席執行官的中位數。此外，Harpreet Singh直接持有公司價值1700萬美元的股票，這意味着他們對公司的成功有深入的投資。
| Component | 2023 | 2022 | Proportion (2023) |
| Salary | €488k | €522k | 8% |
| Other | €5.9m | €7.0m | 92% |
| Total Compensation | €6.4m | €7.5m | 100% |
| 組成部分 | 2023 | 2022 | 比例（2023） |
| 薪資 | 488,000歐元 | 522,000歐元 | 8% |
| 其他 | 5,900,000歐元 | 7,000,000歐元 | 92% |
| 總補償 | 640萬歐元 | 750萬歐元 | 100% |
On an industry level, around 23% of total compensation represents salary and 77% is other remuneration. Immatics sets aside a smaller share of compensation for salary, in comparison to the overall industry. If non-salary compensation dominates total pay, it's an indicator that the executive's salary is tied to company performance.
在行業層面上，總薪酬約佔23%的是工資，77%是其他報酬。與整個行業相比，Immatics把較小的比例的報酬用於工資。如果非工資報酬佔據總報酬的主導地位，則說明執行薪酬與公司表現掛鉤。
Immatics N.V.'s Growth
Immatics N.V.的成長
Immatics N.V. has seen its earnings per share (EPS) increase by 49% a year over the past three years. Its revenue is down 6.6% over the previous year.
過去三年裏，Immatics N.V.的每股收益（EPS）年均增長49%。其營業收入較去年下降6.6%。這表明公司近期表現正在改善，這對股東來說是好消息。當營收不增長時，情況總是很艱難的，但最終利潤更爲重要。展望未來，您可能想查看分析師對公司未來盈利預測的這份免費視覺報告。
This demonstrates that the company has been improving recently and is good news for the shareholders. It's always a tough situation when revenues are not growing, but ultimately profits are more important. Looking ahead, you might want to check this free visual report on analyst forecasts for the company's future earnings..
這證明公司近期表現正在改善，這對股東來說是個好消息。當營收不增長時，情況總是很艱難的，但最終利潤更爲重要。展望未來，您可能想查看分析師對公司未來盈利預測的這份免費視覺報告。
Has Immatics N.V. Been A Good Investment?
Immatics N.V.對股東表現良好嗎？
Immatics N.V. has not done too badly by shareholders, with a total return of 7.5%, over three years. It would be nice to see that metric improve in the future. Accordingly, a proposal to increase CEO remuneration without seeing an improvement in shareholder returns might not be met favorably by most shareholders.
Immatics N.V.的總回報率在三年內達到7.5%。未來期望看到這一指標進一步提升。因此，在未看到股東回報率改善的情況下提議增加首席執行官薪酬，可能不會受到大多數股東的歡迎。
In Summary...
總之……
The company's decent performance might have made most shareholders happy, possibly making CEO remuneration the least of the concerns to be discussed in the upcoming AGM. In saying that, any proposed increase to CEO compensation will still be assessed on how reasonable it is based on performance and industry benchmarks.
公司不錯的表現可能已經讓大多數股東感到滿意，可能使CEO薪酬成爲即將舉行的股東大會上最不用擔心的問題。話雖如此，任何提議增加CEO薪酬的舉措仍將根據績效和行業基準來進行評估。
CEO compensation is an important area to keep your eyes on, but we've also need to pay attention to other attributes of the company. We did our research and identified 3 warning signs (and 1 which is potentially serious) in Immatics we think you should know about.
CEO薪酬是需要關注的重要領域，但我們也需要注意公司的其他屬性。我們進行了研究，並在immatics中確定了3個警告信號（還有1個可能非常嚴重的警告信號），我們認爲您應該知道。
Important note: Immatics is an exciting stock, but we understand investors may be looking for an unencumbered balance sheet and blockbuster returns. You might find something better in this list of interesting companies with high ROE and low debt.
重要提示：immatics是一隻令人興奮的股票，但我們理解投資者可能正在尋找無擔保資產負債表和超額回報。您可以在此列表中找到一些利潤率高、負債率低的有趣公司，有可能找到更好的投資選擇。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋？關於內容有所顧慮？直接和我們聯繫。或者，發送電子郵件至editorial-team (at) simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論，只使用公正的方法論，我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議，也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意，我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
對本文有反饋？關於內容有所顧慮？直接和我們聯繫。或者發送電子郵件至editorial-team@simplywallst.com。
譯文內容由第三人軟體翻譯。